ARCHIVE

#29 – The Tesla of Mental Health?

Brian Normand and David Nickles are joined by Psymposia Senior Writer Russell Hausfeld to discuss MindMed's CEO, Jamon Rahn's, recent claims that his company "may be creating effectively the Tesla of mental health,” and that the company is now a "$1B+ Unicorn.”

Psychedelic Authoritarianism Harm Reduction: “QAnon Shaman” Edition

Jake Angeli's tattoos provide a lens into how fascists and white supremacists have appropriated aspects of Pagan/Heathen culture and spirituality.

#28 – Qoup At The Qapitol: Q’mon Man

In this episode, we discuss a prominent participant in the bumbling coup attempt of January 6: "QAnon Shaman" Jake Angeli. Along with a coalition of Donald Trump supporters and assorted right wing ideologues, Angeli stormed the Capitol following a speech by Trump. Featuring a dissection of an "Ascension Masterclass" that was hosted on Angeli's now-deleted Star Seed Academy Facebook page, we (once again) wade into the disturbing world of psychedelic authoritarianism.

Jake Angeli: The Psychedelic Guru Who Stormed The Capitol

Capitol insurrectionist Jake Angeli is a self-appointed psychedelic guru who has opined about the urgent need for psychedelic shamanism to heal the world’s biggest problems.

Psymposia 2020 Staff Book Picks

The Psymposia staff reflects on some of the books that kept us company throughout 2020, which we'd like to recommend to our readers for 2021. The list includes works of intersectional analysis, psychedelic history, surveillance capitalism, and more. We hope you appreciate these insights as much as we do.

#27 – The Thought Leader and the Critic

This episode explores the rise of self-styled “thought leaders” within the psychedelic community, using Anand Giridharadas’ book “Winners Take All” as a jumping off point. Although people have been on the conference circuit for years, the recent explosion of capital investments means that there’s an unprecedented potential for money, celebrity, and status in the space.

Livestream #2: Team trip reports and experiential typewriters

Weeoo weeoo livestream alert for Thursday, December 17th at 8PM ET!!. Last time we popped bottles and jammed in the comments - come hang out with us again for some reflections on 2020.

Christopher Valore (AKA The Architect) talks “Conductor,” His Virtual-Reality, Psychedelic-Visual Sandbox Platform

Christopher Valore discusses his love of virtual reality; the early days of his company, Club Transcendia; and development of his first official release, “Conductor.”

#26 – Livestream: The Gang Goes Non-Profit

We kicked off the start of our ongoing livestreams with the announcement of Psymposia's 501(c)(3) non-profit status, discussions of corporadelic dynamics, fond memories of helping people learn how to extract psychedelic drugs during an Ivy League University's psychedelic conference, and a whole bunch of back and forth with the audience about the current state (and future) of psychedelia.

#25 – Press Release: Plus Three found to have neuroprotective effects against corporadelic BS

In this episode we explore the myriad of problems that result from media outlets treating corporate press releases as though they're legitimate news sources, rather than advertisements. We examine "science by press release" cases ranging from psychedelic pharmaceutical firms who claim their barely-studied compounds are superior to (and safer than) psilocybin (one of the safest psychoactive compounds in the human pharmacopoeia), to students who claimed Oreos were as addictive as cocaine, to pineal DMT, cold fusion, and more.

#24 – From Mining to Mushrooms

Recorded live at the Capital Psychedelic Summit, hosted virtually in Washington D.C., Russell Hausfeld joins Brian Normand and David Nickles to discuss the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry. This episode explores the destructive nature of extractive industry and the effects of introducing those dynamics into psychedelia. If the same people destroying Indigenous lands told you they believed in "sacred reciprocity," would you believe them?

Thea Riofrancos on the Implications of Global Energy Transition and the Impacts of Lithium Extraction

Thea Riofrancos is a political scientist whose research has focused on political conflict related to extraction, energy, and infrastructure in a rapidly warming and politically unstable world. She also serves on the steering committee for Democratic Socialists of America for a Green New Deal.

The Big & Dandy List of Psychedelic-Mining-Extractive-Industry Ties

This list is by no means exhaustive, but it spotlights a number of psychedelic pharmaceutical companies and executives with ties to extractive industry.

Why are so many extractive industry executives speculating on psychedelics?

Extractive industry is highly speculative by nature and firms are risk tolerant—they either “strike gold” or they don’t. When their gambles fail, psychedelic startups can take over their corporate shells to quickly go public with minimal regulatory scrutiny.

Will Extractive Industry Bring Its Disregard for Indigenous People Into The Psychedelic Industry?

A mining firm’s conflict with Argentinian communities illustrates extractive industry’s practices and values, and raises questions about how these corporate approaches will translate into the psychedelic pharmaceutical industry.

As Psychedelics Enter the Mainstream, Mining Companies Look to Dig Up Profits

Canadian mining and exploration company AIS has had a number of executives move on to found psychedelic pharmaceutical businesses. Why? Because psychedelics are where the money’s at.

#23 – “Grow, Gather, Give” Is an Anti-Capitalist Approach (and That’s a Good Thing)

Recorded live (online) at the Capital Psychedelic Summit in Washington D.C., the Plus Three crew picks up the threads of a recent panel discussion about the effects of corporations and capitalism on the emerging psychedelic landscape. Examining the logic of capitalism, the realities of medicalization, and the need for radical social transformations, we explore philosophies underlying the "Grow, Gather, Give" model, which the Capital Psychedelic Summit organizers explicitly centered for this event.

An Open Letter and Call to Action for MAPS Canada

The following is an open letter by two former co-leads of the MAPS Canada Diversity Committee. It was written in response to a variety of racist and prejudicial behaviours they experienced from MAPS Canada leadership and the organization at large during their eight-month tenure as unpaid volunteers, including obstruction—by leadership—of their efforts to address long-entrenched discriminatory practices in the psychedelic research domain and to implement initiatives to combat race-based health disparities.

Psychedelic Media Should Stop Parroting Corporate Press Releases

When the media republishes statements from psychedelic pharmaceutical startups and their executives with little-to-no vetting, it functions as a corporate megaphone and damages the field of psychedelic science.

#22 – Coronavirus Conspiracy Theories in Psychedelia

Terence McKenna once mused, “Conspiracy theory is a kind of epistemological cartoon about reality.” Looking around at the world, things appear awfully cartoonish at the moment. We're joined by Psymposia Senior Writer, Russell Hausfeld, to discuss the propagation of coronavirus conspiracies, recent revelations about QAnon, and the likelihood that some "conspiracy" claims are simply warped articulations of systemic critique. 5G won't give you COVID-19, but it sure will help you download this episode faster.

ATAI Life Sciences Company, EmpathBio, Dives Into MDMA Derivatives, Calls MAPS’ Approach “MDMA 1.0”

Through EmpathBio, ATAI Life Sciences says it will develop “safer” MDMA derivatives for patients with PTSD and calls the Multidisciplinary Association for Psychedelic Studies' (MAPS) approach "MDMA 1.0." MAPS' executive director, Rick Doblin, says that if that's the case, ATAI is "MDMA 0.5."

As COMPASS Pathways continues its attempts to build a psychedelic monopoly, Usona Institute keeps publishing open research

Since COMPASS Pathways filed for a controversial psilocybin patent in 2018, Usona Institute has consistently placed its research findings in the public domain.

#21 – American Trip: Ido Hartogsohn

Dr. Ido Hartoghson joins the show to talk about the ideas in his new book, American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century  Acknowledging psychedelics as non-specific amplifiers of consciousness, we discuss different historical (and present) paradigms of use in order to interrogate the role of psychedelics within our culture. As we find ourselves staring down a number of existential questions, we must ask ourselves, "What do we hope to achieve through our personal and cultural exposure to psychedelics?”

Coronavirus Conspiracy Theories in Psychedelia

Conspiracy theories are nothing new when it comes to psychedelia. But in the context of coronavirus, they've become significantly more harmful.

#20 – The LSD Silo Bust (Everything You Wanted to Know and a Few Things You Didn’t)

In response to the unexpected early release of William Leonard Pickard from prison, we discuss some of the characters and stories surrounding the case. Having served twenty years of a double life sentence for conspiracy to manufacture, distribute, and dispense LSD— charges which he disputes— Pickard has never spoken publicly about the specifics of his case, and some of the drug-media coverage of this story has evidenced glaring omissions. Using court documents, lesser-known first-person accounts, and excerpts from Pickard's book, The Rose of Paracelsus: On Secrets & Sacraments, we call attention to some of the murkier aspects of this story in an attempt to paint a fuller picture of what is, perhaps, the most notorious psychedelic story of the 21st century.


ARCHIVE

#29 – The Tesla of Mental Health?

Brian Normand and David Nickles are joined by Psymposia Senior Writer Russell Hausfeld to discuss MindMed's CEO, Jamon Rahn's, recent claims that his company "may be creating effectively the Tesla of mental health,” and that the company is now a "$1B+ Unicorn.”

Psychedelic Authoritarianism Harm Reduction: “QAnon Shaman” Edition

Jake Angeli's tattoos provide a lens into how fascists and white supremacists have appropriated aspects of Pagan/Heathen culture and spirituality.

#28 – Qoup At The Qapitol: Q’mon Man

In this episode, we discuss a prominent participant in the bumbling coup attempt of January 6: "QAnon Shaman" Jake Angeli. Along with a coalition of Donald Trump supporters and assorted right wing ideologues, Angeli stormed the Capitol following a speech by Trump. Featuring a dissection of an "Ascension Masterclass" that was hosted on Angeli's now-deleted Star Seed Academy Facebook page, we (once again) wade into the disturbing world of psychedelic authoritarianism.

Jake Angeli: The Psychedelic Guru Who Stormed The Capitol

Capitol insurrectionist Jake Angeli is a self-appointed psychedelic guru who has opined about the urgent need for psychedelic shamanism to heal the world’s biggest problems.

Psymposia 2020 Staff Book Picks

The Psymposia staff reflects on some of the books that kept us company throughout 2020, which we'd like to recommend to our readers for 2021. The list includes works of intersectional analysis, psychedelic history, surveillance capitalism, and more. We hope you appreciate these insights as much as we do.

#27 – The Thought Leader and the Critic

This episode explores the rise of self-styled “thought leaders” within the psychedelic community, using Anand Giridharadas’ book “Winners Take All” as a jumping off point. Although people have been on the conference circuit for years, the recent explosion of capital investments means that there’s an unprecedented potential for money, celebrity, and status in the space.

Livestream #2: Team trip reports and experiential typewriters

Weeoo weeoo livestream alert for Thursday, December 17th at 8PM ET!!. Last time we popped bottles and jammed in the comments - come hang out with us again for some reflections on 2020.

Christopher Valore (AKA The Architect) talks “Conductor,” His Virtual-Reality, Psychedelic-Visual Sandbox Platform

Christopher Valore discusses his love of virtual reality; the early days of his company, Club Transcendia; and development of his first official release, “Conductor.”

#26 – Livestream: The Gang Goes Non-Profit

We kicked off the start of our ongoing livestreams with the announcement of Psymposia's 501(c)(3) non-profit status, discussions of corporadelic dynamics, fond memories of helping people learn how to extract psychedelic drugs during an Ivy League University's psychedelic conference, and a whole bunch of back and forth with the audience about the current state (and future) of psychedelia.

#25 – Press Release: Plus Three found to have neuroprotective effects against corporadelic BS

In this episode we explore the myriad of problems that result from media outlets treating corporate press releases as though they're legitimate news sources, rather than advertisements. We examine "science by press release" cases ranging from psychedelic pharmaceutical firms who claim their barely-studied compounds are superior to (and safer than) psilocybin (one of the safest psychoactive compounds in the human pharmacopoeia), to students who claimed Oreos were as addictive as cocaine, to pineal DMT, cold fusion, and more.

#24 – From Mining to Mushrooms

Recorded live at the Capital Psychedelic Summit, hosted virtually in Washington D.C., Russell Hausfeld joins Brian Normand and David Nickles to discuss the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry. This episode explores the destructive nature of extractive industry and the effects of introducing those dynamics into psychedelia. If the same people destroying Indigenous lands told you they believed in "sacred reciprocity," would you believe them?

Thea Riofrancos on the Implications of Global Energy Transition and the Impacts of Lithium Extraction

Thea Riofrancos is a political scientist whose research has focused on political conflict related to extraction, energy, and infrastructure in a rapidly warming and politically unstable world. She also serves on the steering committee for Democratic Socialists of America for a Green New Deal.

The Big & Dandy List of Psychedelic-Mining-Extractive-Industry Ties

This list is by no means exhaustive, but it spotlights a number of psychedelic pharmaceutical companies and executives with ties to extractive industry.

Why are so many extractive industry executives speculating on psychedelics?

Extractive industry is highly speculative by nature and firms are risk tolerant—they either “strike gold” or they don’t. When their gambles fail, psychedelic startups can take over their corporate shells to quickly go public with minimal regulatory scrutiny.

Will Extractive Industry Bring Its Disregard for Indigenous People Into The Psychedelic Industry?

A mining firm’s conflict with Argentinian communities illustrates extractive industry’s practices and values, and raises questions about how these corporate approaches will translate into the psychedelic pharmaceutical industry.

As Psychedelics Enter the Mainstream, Mining Companies Look to Dig Up Profits

Canadian mining and exploration company AIS has had a number of executives move on to found psychedelic pharmaceutical businesses. Why? Because psychedelics are where the money’s at.

#23 – “Grow, Gather, Give” Is an Anti-Capitalist Approach (and That’s a Good Thing)

Recorded live (online) at the Capital Psychedelic Summit in Washington D.C., the Plus Three crew picks up the threads of a recent panel discussion about the effects of corporations and capitalism on the emerging psychedelic landscape. Examining the logic of capitalism, the realities of medicalization, and the need for radical social transformations, we explore philosophies underlying the "Grow, Gather, Give" model, which the Capital Psychedelic Summit organizers explicitly centered for this event.

An Open Letter and Call to Action for MAPS Canada

The following is an open letter by two former co-leads of the MAPS Canada Diversity Committee. It was written in response to a variety of racist and prejudicial behaviours they experienced from MAPS Canada leadership and the organization at large during their eight-month tenure as unpaid volunteers, including obstruction—by leadership—of their efforts to address long-entrenched discriminatory practices in the psychedelic research domain and to implement initiatives to combat race-based health disparities.

Psychedelic Media Should Stop Parroting Corporate Press Releases

When the media republishes statements from psychedelic pharmaceutical startups and their executives with little-to-no vetting, it functions as a corporate megaphone and damages the field of psychedelic science.

#22 – Coronavirus Conspiracy Theories in Psychedelia

Terence McKenna once mused, “Conspiracy theory is a kind of epistemological cartoon about reality.” Looking around at the world, things appear awfully cartoonish at the moment. We're joined by Psymposia Senior Writer, Russell Hausfeld, to discuss the propagation of coronavirus conspiracies, recent revelations about QAnon, and the likelihood that some "conspiracy" claims are simply warped articulations of systemic critique. 5G won't give you COVID-19, but it sure will help you download this episode faster.

ATAI Life Sciences Company, EmpathBio, Dives Into MDMA Derivatives, Calls MAPS’ Approach “MDMA 1.0”

Through EmpathBio, ATAI Life Sciences says it will develop “safer” MDMA derivatives for patients with PTSD and calls the Multidisciplinary Association for Psychedelic Studies' (MAPS) approach "MDMA 1.0." MAPS' executive director, Rick Doblin, says that if that's the case, ATAI is "MDMA 0.5."

As COMPASS Pathways continues its attempts to build a psychedelic monopoly, Usona Institute keeps publishing open research

Since COMPASS Pathways filed for a controversial psilocybin patent in 2018, Usona Institute has consistently placed its research findings in the public domain.

#21 – American Trip: Ido Hartogsohn

Dr. Ido Hartoghson joins the show to talk about the ideas in his new book, American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century  Acknowledging psychedelics as non-specific amplifiers of consciousness, we discuss different historical (and present) paradigms of use in order to interrogate the role of psychedelics within our culture. As we find ourselves staring down a number of existential questions, we must ask ourselves, "What do we hope to achieve through our personal and cultural exposure to psychedelics?”

Coronavirus Conspiracy Theories in Psychedelia

Conspiracy theories are nothing new when it comes to psychedelia. But in the context of coronavirus, they've become significantly more harmful.

#20 – The LSD Silo Bust (Everything You Wanted to Know and a Few Things You Didn’t)

In response to the unexpected early release of William Leonard Pickard from prison, we discuss some of the characters and stories surrounding the case. Having served twenty years of a double life sentence for conspiracy to manufacture, distribute, and dispense LSD— charges which he disputes— Pickard has never spoken publicly about the specifics of his case, and some of the drug-media coverage of this story has evidenced glaring omissions. Using court documents, lesser-known first-person accounts, and excerpts from Pickard's book, The Rose of Paracelsus: On Secrets & Sacraments, we call attention to some of the murkier aspects of this story in an attempt to paint a fuller picture of what is, perhaps, the most notorious psychedelic story of the 21st century.